Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

Rob Pieters; Paola De Lorenzo; Philip Ancliffe; Luis Aversa; Benoît Brethon; Andrea Biondi; Myriam Campbell; Gabriele Escherich; Alina Ferster; Rebecca Gardner; Rishi S. Kotecha; Birgitte Lausen; Chi Kong Li; Franco Locatelli; Andishe Attarbaschi; Christina Peters; Jeffrey E. Rubnitz; Lewis B. Silverman; Jan Starý; Tomasz Szczepański; Ajay Vora; Martin Schrappe; Maria Grazia Valsecchi

doi:10.1200/jco.19.00261

Abstract

Early intensification with postinduction myeloid-type chemotherapy courses did not significantly improve outcome for infant ALL compared with the lymphoid-type course IB. Outcome for infant ALL in Interfant-06 did not improve compared with that in Interfant-99.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pieters et al. (2019) studied this question.

synapsesocial.com/papers/69d819f9b5518339b2ae2cbf https://doi.org/10.1200/jco.19.00261

View Full Paper

Ask AI

Bookmark

Share

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

Abstract

Discussion

Cite This Study

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

Abstract

Discussion

Cite This Study

Keep reading

Keep reading